The proposed mechanism for these findings is as follows; in prostate cancer, androgen is bound to AR, which activates HIF-1α through a cascade of several protein kinase systems, continuously increasing expression of the HIF-1α-related gene, one of which is BNIP3. The gene discussed is WEE1; the disease is prostate carcinoma.